Aviva PLC Jazz Pharmaceuticals PLC Transaction History

Aviva PLC

$36.8 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$115.19 - $132.77 $2,303 - $2,655	-20 Reduced 0.85%	2,344 $282,000
Q3 2023 Nov 13, 2023	SELL	$122.0 - $145.31 $6,222 - $7,410	-51 Reduced 2.11%	2,364 $305,000
Q1 2023 May 12, 2023	SELL	$133.98 - $160.47 $791,151 - $947,575	-5,905 Reduced 70.97%	2,415 $353,000
Q4 2022 Feb 09, 2023	SELL	$129.72 - $159.85 $10.1 Million - $12.5 Million	-78,188 Reduced 90.38%	8,320 $1.33 Million
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $6.17 Million - $7.86 Million	48,771 Added 129.24%	86,508 $11.5 Million
Q2 2022 Aug 04, 2022	SELL	$141.59 - $168.66 $321,126 - $382,520	-2,268 Reduced 5.67%	37,737 $5.89 Million
Q1 2022 May 13, 2022	BUY	$129.64 - $160.7 $2.41 Million - $2.99 Million	18,628 Added 87.14%	40,005 $6.23 Million
Q4 2021 Feb 10, 2022	BUY	$119.87 - $145.67 $397,968 - $483,624	3,320 Added 18.39%	21,377 $2.72 Million
Q3 2021 Nov 12, 2021	SELL	$128.64 - $184.79 $60,589 - $87,036	-471 Reduced 2.54%	18,057 $2.35 Million
Q2 2021 Aug 10, 2021	BUY	$160.2 - $186.42 $55,749 - $64,874	348 Added 1.91%	18,528 $3.29 Million
Q1 2021 May 13, 2021	BUY	$150.19 - $173.5 $51,364 - $59,337	342 Added 1.92%	18,180 $2.99 Million
Q4 2020 Feb 10, 2021	BUY	$140.71 - $165.05 $41,228 - $48,359	293 Added 1.67%	17,838 $2.94 Million
Q3 2020 Nov 12, 2020	SELL	$105.46 - $144.13 $63,170 - $86,333	-599 Reduced 3.3%	17,545 $2.5 Million
Q2 2020 Aug 13, 2020	SELL	$95.68 - $121.88 $122,087 - $155,518	-1,276 Reduced 6.57%	18,144 $2 Million
Q1 2020 May 14, 2020	SELL	$87.74 - $152.74 $1,667 - $2,902	-19 Reduced 0.1%	19,420 $1.94 Million
Q4 2019 Feb 10, 2020	SELL	$117.65 - $153.73 $5,176 - $6,764	-44 Reduced 0.23%	19,439 $2.9 Million
Q3 2019 Nov 12, 2019	SELL	$125.18 - $143.24 $274,269 - $313,838	-2,191 Reduced 10.11%	19,483 $2.5 Million
Q2 2019 Jul 30, 2019	SELL	$125.55 - $144.48 $76,836 - $88,421	-612 Reduced 2.75%	21,674 $3.09 Million
Q1 2019 May 14, 2019	BUY	$121.81 - $142.95 $23,996 - $28,161	197 Added 0.89%	22,286 $3.19 Million
Q4 2018 Feb 12, 2019	SELL	$115.94 - $166.74 $742,131 - $1.07 Million	-6,401 Reduced 22.47%	22,089 $2.74 Million
Q3 2018 Nov 13, 2018	SELL	$161.01 - $180.57 $159,882 - $179,306	-993 Reduced 3.37%	28,490 $4.79 Million
Q2 2018 Aug 01, 2018	SELL	$146.33 - $183.18 $17,266 - $21,615	-118 Reduced 0.4%	29,483 $5.08 Million
Q1 2018 May 14, 2018	SELL	$135.59 - $157.16 $461,141 - $534,501	-3,401 Reduced 10.31%	29,601 $4.47 Million
Q4 2017 Feb 13, 2018	SELL	$131.06 - $150.39 $422,406 - $484,706	-3,223 Reduced 8.9%	33,002 $4.44 Million
Q3 2017 Nov 13, 2017	BUY	$142.62 - $155.6 $124,079 - $135,372	870 Added 2.46%	36,225 $5.3 Million
Q2 2017 Aug 07, 2017	BUY	N/A	35,355	35,355 $5.5 Million

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account